This Article Full Text Full Text (PDF) Other Versions of this Article: IAI.01280-06v1 75/2/666    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Murthy, A. K. Articles by Arulanandam, B. P. Search for Related Content PubMed PubMed Citation Articles by Murthy, A. K. Articles by Arulanandam, B. P.

 Previous Article  |  Next Article 

Infection and Immunity, February 2007, p. 666-676, Vol. 75, No. 2
0019-9567/07/$08.00+0     doi:10.1128/IAI.01280-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Intranasal Vaccination with a Secreted Chlamydial Protein Enhances Resolution of Genital Chlamydia muridarum Infection, Protects against Oviduct Pathology, and Is Highly Dependent upon Endogenous Gamma Interferon Production

Department of Biology, South Texas Center for Emerging Infectious Diseases, University of Texas at San Antonio, San Antonio, Texas 78249,¹ Department of Pathology, Wilford Hall Medical Center, San Antonio, Texas 78236,² Department of Microbiology and Immunology, University of Texas Health Science Center, San Antonio, Texas 78229³

Received 9 August 2006/ Returned for modification 26 September 2006/ Accepted 6 November 2006

There is currently no licensed vaccine against Chlamydia trachomatis, the leading cause of sexually transmitted bacterial disease worldwide. Conventional vaccination attempts using surface-exposed chlamydial antigens have achieved only partial success. We have employed a novel vaccination strategy using a secreted protein, chlamydial protease-like activity factor (CPAF), which has been shown to degrade host major histocompatibility complex transcription factors and keratin-8 and therefore may allow immune evasion and establishment of a productive infection. Intranasal immunization using recombinant CPAF (rCPAF) plus interleukin-12 (IL-12) (rCPAF+IL-12 immunization) was used to assess the protective immunity against genital Chlamydia muridarum infection in BALB/c mice. rCPAF+IL-12 immunization induced robust gamma interferon (IFN-) production and minimal IL-4 production by splenocytes upon in vitro recall with rCPAF. The total and immunoglobulin G2a (IgG2a) anti-rCPAF antibody levels in serum were significantly elevated after rCPAF+IL-12 vaccination, as were the total antibody, IgG2a, and IgA levels in bronchoalveolar lavage and vaginal fluids when the animals were compared to animals that received rCPAF alone. rCPAF+IL-12-vaccinated mice displayed significantly reduced bacterial shedding upon chlamydial challenge and accelerated resolution of infection compared to mock-immunized (phosphate-buffered saline) animals. Moreover, rCPAF+IL-12-immunized animals exhibited protection against pathological consequences of chlamydial infection, including the development of hydrosalpinx and oviduct dilatation. This vaccination regimen also reduced the development of fibrosis and the influx of neutrophils into the upper genital tract when the animals were compared to mock-immunized (phosphate-buffered saline) animals after bacterial challenge. rCPAF+IL-12-mediated resolution of the bacterial infection and protection against Chlamydia-induced inflammatory disease were highly dependent on endogenous IFN- production. Together, these results demonstrate that secreted chlamydial antigens may be novel vaccine candidates to induce protective immunity.

Published ahead of print on 21 November 2006.

Editor: F. C. Fang

This article has been cited by other articles:

• Jupelli, M., Guentzel, M. N., Meier, P. A., Zhong, G., Murthy, A. K., Arulanandam, B. P. (2008). Endogenous IFN-{gamma} Production Is Induced and Required for Protective Immunity against Pulmonary Chlamydial Infection in Neonatal Mice. J. Immunol. 180: 4148-4155 [Abstract] [Full Text]  
• Li, W., Murthy, A. K., Guentzel, M. N., Seshu, J., Forsthuber, T. G., Zhong, G., Arulanandam, B. P. (2008). Antigen-Specific CD4+ T Cells Produce Sufficient IFN-{gamma} to Mediate Robust Protective Immunity against Genital Chlamydia muridarum Infection. J. Immunol. 180: 3375-3382 [Abstract] [Full Text]  
• Cheng, W., Shivshankar, P., Li, Z., Chen, L., Yeh, I-T., Zhong, G. (2008). Caspase-1 Contributes to Chlamydia trachomatis-Induced Upper Urogenital Tract Inflammatory Pathologies without Affecting the Course of Infection. Infect. Immun. 76: 515-522 [Abstract] [Full Text]  
• Li, W., Guentzel, M. N., Seshu, J., Zhong, G., Murthy, A. K., Arulanandam, B. P. (2007). Induction of Cross-Serovar Protection against Genital Chlamydial Infection by a Targeted Multisubunit Vaccination Approach. CVI 14: 1537-1544 [Abstract] [Full Text]  
• O'Connell, C. M., Ingalls, R. R., Andrews, C. W. Jr., Scurlock, A. M., Darville, T. (2007). Plasmid-Deficient Chlamydia muridarum Fail to Induce Immune Pathology and Protect against Oviduct Disease. J. Immunol. 179: 4027-4034 [Abstract] [Full Text]